Golden
UT Horizon Fund

UT Horizon Fund

UT Horizon Fund is the venture fund of the University of Texas System. It aims to improve the commercialization of technologies out of research at UT System institutions

UT Horizon Fund is a venture capital firm in Austin that prefers to invest in companies within the technology sector. Founded 2011 in Austin, Texas, the firm invests in early stage and late stage ventures. The notable investment portfolio of UT Horizon Fundincludes Cerebri AI, GenXComm, Astrocyte Pharmaceuticals, Lung Therapeutics, Alafair Biosciences, Decisio Health, and MicroTransponder. As of January 2020, UT Horizon Fund has made 30 investments and 6 exits. Their most recent investment was on Dec 4, 2019, when Cerebri AI raised $7M. 



Timeline

2011

Founded

Funded Companies

Company
Description
Website
Industry
Location
3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Bryan Allinson

Founder and Executive Director



Carlos Kemeny

Director for Entrepreneurship Network



Gus Johnson

Assistant Director



Julie Goonewardene

Managing Director



Matt Sorenson

Investment Analyst



Nick Tulloh

Senior Investment Analyst



Suruchi Parwal

Senior Investment Analyst



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

Alafair Biosciences







Astrocyte Pharmaceuticals







Cerebri AI







Decisio Health







GenXComm







Lung Therapeutics







Lung Therapeutics







MicroTransponder







References